Blueprint Medicines (BPMC) – Analyst Comments
-
Oppenheimer Upgrades Blueprint Medicines (BPMC) to Outperform; 'We Want In on this Launch'
-
Berenberg Out Positive on Blueprint Medicines (BPMC): 'we came away with a positive outlook for first-in-class drug Ayvakit'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BPMC Stock Lookup